World's First AI Clinic Begins Operations in Saudi Arabia
In an unprecedented global move, Chinese startup Sinohey AI has announced the opening of the world's first fully AI-powered medical clinic in the Al-Ahsa region of eastern Saudi Arabia, in collaboration with Al-Mousa Health Group.
This pilot project follows promising results from the company's AI model, which recorded an error rate of less than 0.3% in previous tests—comparable to human error in medical diagnoses, according to a report by Bloomberg.
The initiative is still in its early stages, with the AI model currently available to a limited number of patients for free. A human doctor remains present to oversee the diagnostic and treatment processes.
After each consultation, the medical reports and decisions generated by the AI are submitted to Saudi health authorities for review and accuracy checks, in preparation for official licensing within the next 18 months, according to company CEO Zhang Shaodian.
The clinic operates through direct interaction between the patient and the intelligent model, named Dr. Hua, via tablets available on-site. Patients enter their symptoms, after which the model may request lab tests or imaging, which are carried out by qualified medical staff. The AI then analyzes the results and suggests a treatment plan, which is reviewed by an independent human doctor before being given to the patient.
Currently, Dr. Hua can diagnose around 30 types of respiratory diseases. The company aims to expand this to 50 conditions, including those affecting the respiratory, dermatological, and digestive systems. Coordination with Saudi authorities is ongoing to expand the trial and open additional AI-based clinics in the coming months.
Despite the company's long-term goal of eliminating the need for human doctors in non-emergency cases, the current model is still under strict human supervision. A physician must be on-site and ready to intervene when needed, ensuring a balance between technological innovation and medical safety.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Alalam24
6 days ago
- Alalam24
World's First AI Clinic Begins Operations in Saudi Arabia
In an unprecedented global move, Chinese startup Sinohey AI has announced the opening of the world's first fully AI-powered medical clinic in the Al-Ahsa region of eastern Saudi Arabia, in collaboration with Al-Mousa Health Group. This pilot project follows promising results from the company's AI model, which recorded an error rate of less than 0.3% in previous tests—comparable to human error in medical diagnoses, according to a report by Bloomberg. The initiative is still in its early stages, with the AI model currently available to a limited number of patients for free. A human doctor remains present to oversee the diagnostic and treatment processes. After each consultation, the medical reports and decisions generated by the AI are submitted to Saudi health authorities for review and accuracy checks, in preparation for official licensing within the next 18 months, according to company CEO Zhang Shaodian. The clinic operates through direct interaction between the patient and the intelligent model, named Dr. Hua, via tablets available on-site. Patients enter their symptoms, after which the model may request lab tests or imaging, which are carried out by qualified medical staff. The AI then analyzes the results and suggests a treatment plan, which is reviewed by an independent human doctor before being given to the patient. Currently, Dr. Hua can diagnose around 30 types of respiratory diseases. The company aims to expand this to 50 conditions, including those affecting the respiratory, dermatological, and digestive systems. Coordination with Saudi authorities is ongoing to expand the trial and open additional AI-based clinics in the coming months. Despite the company's long-term goal of eliminating the need for human doctors in non-emergency cases, the current model is still under strict human supervision. A physician must be on-site and ready to intervene when needed, ensuring a balance between technological innovation and medical safety.
Morocco World
22-05-2025
- Morocco World
Gotion Gigafactory Construction Launches Within Days in Kenitra
Doha – Construction of Africa's inaugural gigafactory will commence within days in Kenitra. Gotion Power Morocco has finalized preparatory groundwork for the colossal battery manufacturing facility. The Sino-European electric vehicle battery behemoth signed an investment accord with Rabat in June 2023. The comprehensive agreement encompasses a staggering $6.5 billion commitment across five developmental phases. Khalid Qalam, Gotion's Moroccan director, announced the imminent construction launch during Wednesday's industrial conference in Rabat. Terrassement operations have reached completion, and production inauguration is slated for the third quarter of 2026. The initial phase demands $1.3 billion in capital expenditure. Manufacturing capacity will reach 20 gigawatts. Government negotiations have secured approval for capacity expansion to 40 GW in the second phase, culminating in 100 GWh total capacity across all five phases. The facility will achieve remarkable vertical integration from inception. Nearly 70% of battery production costs will originate domestically. This unprecedented localization strategy positions Morocco competitively against global rivals. Manufacturing will encompass batteries, cathodes, and anodes. European markets constitute the primary export destination. The company has already secured numerous orders from European automotive manufacturers. Phase one will generate 2,300 employment opportunities. The complete five-phase project will create 10,000 positions across the industrial complex. Morocco's automotive sector achieved record-breaking performance in 2024. Export revenues reached MAD 157 billion ($15.7 billion), representing a 6.3% annual surge. The country surpassed China, Japan, and India to become the European Union's leading automotive exporter in 2023. Gotion anticipates serving dual market segments. Automotive applications will primarily target European manufacturers alongside Moroccan production zones. Renault and Stellantis maintain an established manufacturing presence within the country. Energy storage represents the second pivotal market. Morocco, Africa, and Middle Eastern regions benefit from approximately 300 annual sunshine days. This climatic advantage creates exceptional growth potential for renewable energy storage solutions. Last year, two-thirds of Gotion's revenue originated from energy storage applications. Mobility accounted for the remaining third. Residential energy storage markets are projected to explode over the forthcoming decade. The project represents one component of extensive Chinese investment proliferation across Morocco. Chinese automotive investments have reached approximately $10 billion in recent years through Belt and Road Initiative financing. Beijing now views Morocco as a critical gateway to European markets, allowing Chinese firms to bypass tariff barriers. The country's advanced transport infrastructure — including the Tangier-Med port — along with abundant phosphate reserves vital for battery production, enhance its industrial attractiveness. Morocco's swift transition to clean energy further boosts its appeal to foreign investors. Strategically located just south of Europe, Morocco benefits from its proximity and its comprehensive free trade agreement with the European Union — making it an increasingly valuable partner in global supply chains. Tags: chinese investments in MoroccogigafactoryGotion High-Tech
Alalam24
21-05-2025
- Alalam24
Artificial Intelligence Surpasses Virologists
Artificial intelligence is no longer just a limited technical tool; it has evolved into a cross-disciplinary cognitive force capable of redefining the boundaries of the human mind. While it has already proven its superiority in fields like chess and data analysis, its rapid progress in complex disciplines such as virology now raises pressing questions about its future and potential consequences. Alongside its achievements come existential concerns that require thoughtful, collective reflection. In this context, a new study has shown that modern AI models are beginning to outperform human experts in solving advanced laboratory problems. OpenAI's 'o3' model surpassed PhD-level scientists in tests specifically designed to measure skills in identifying and fixing errors in biological lab protocols. Similarly, Google's 'Gemini 2.5 Pro' achieved a performance rate of 37.6%, compared to an average of just 22.1% among human specialists. While these results may represent a breakthrough in fighting pandemics and accelerating medical innovation, they also pose serious risks—especially if such capabilities fall into the hands of unqualified users. Seth Donahue, a researcher at SecureBio, expressed concern that these models could be used as technical guides for developing biological weapons, emphasizing that AI does not discern user intent—it simply provides information without ethical judgment. Some AI companies, such as OpenAI and xAI, have proactively implemented precautionary measures to limit these risks. Others, like Anthropic, have included the study without announcing any clear plans, while Google declined to comment on the results, which were published exclusively in Time magazine—raising further concerns among researchers about the seriousness of collective ethical commitments in AI development. Virology has not been a random focus; it has long been one of the key drivers behind AI advancement. Sam Altman, CEO of OpenAI, stated that this technology has the potential to dramatically accelerate disease treatment. One encouraging example comes from researchers at the University of Florida, who developed an algorithm capable of predicting coronavirus mutations—boosting hopes for AI's role in protecting public health. Still, the lack of extensive studies on AI's ability to perform real laboratory tasks remained a clear gap. To address this, the research team designed highly specific tests that simulate problems difficult to solve through simple online searches, requiring deep analysis of realistic lab scenarios. The questions were framed in a practical manner, such as: 'I'm culturing this virus in a specific type of cell under certain conditions. A problem has occurred—can you identify the most likely error?' These tests weren't intended to question scientists' capabilities but rather to assess AI's feasibility as an assistant or potential alternative. While some view these advancements with optimism, others sound the alarm—especially as open-source models progress and make access to sensitive knowledge easier, often without sufficient safeguards. Thus, the future of AI in virology hangs between two stark possibilities: either it becomes a lifeline for humanity, or an unprecedented threat—unless its advancement is accompanied by equal progress in awareness, accountability, and strict global regulation.
